Resilience helps protect performance through disease, environmental or management challenges. Resistance helps limit specific disease threats.
Different tools. Different purposes. One shared goal: a more robust pig.
By advancing both, we can build genetics better equipped for the realities of commercial pork production – today and in the future.
See how we’re advancing both:

A healthy supply starts long before it reaches the farm.
Strategic centre location, environmental assessment, quarantine and biosecurity all help reduce risk from the source. These are not just operational details — they are part of protecting continuity and confidence.
Learn what stands behind a healthy, reliable supply.
When it comes to genetic progress, our answer is both.
Commercial herds rarely face a single challenge at a time. Health pressures, environmental variation, feed changes and management shifts can all affect performance.
That’s why we believe the future of genetic progress is robustness – bringing resilience and resistance together to help pigs perform more consistently in real-world production conditions.
Dig deeper into the science and strategy behind robustness:

When it is time to inseminate, supply cannot fail.
For UK producers, reliability means more than delivery on time. It depends on coordinated logistics, strong biosecurity, controlled processes and continuity built into the system behind every dose.
Discover how PIC builds reliable supply for the farm. 
Better breeding decisions start with better data.
Genomics and digital phenotyping help make selection more precise, repeatable and linked to real pig performance. For producers and the wider pork chain, that means progress that is faster, practical and reliable.
Explore how digital tools are shaping terminal sire improvement.
Genetic potential only creates value when it performs on farm.
PIC’s GNX programme uses commercial crossbred pig data to help identify the families that deliver under real production conditions — from growth and feed intake to structure and carcass traits.
Read more about how commercial data supports practical genetic progress.
No single terminal sire is the perfect fit for every market.
UK producers need genetics that connect on-farm performance with carcass value and customer requirements. PIC’s sire line portfolio is built on reliable data, clear selection goals and commercial validation.
Discover how the right sire choice can support your production goals.
One terminal sire choice can shape the performance of thousands of pigs.
Its value is seen later in growth, feed efficiency, survivability, carcass value and pork quality. That’s why the genetic programme behind the sire matters as much as the product itself.
Learn more about how PIC drives repeatable genetic progress: 
Body condition is more useful when you track how it changes.Analysis of 1,424 first-parity PIC Camborough
sows found an average change of around 5% loss in caliper-measured condition from entry to farrowing through weaning — but individual results varied considerably.Monitoring these changes can help identify opportunities to adjust lactation feeding, litter management and sow monitoring.
Read the full article and explore the findings: 
New advances in genomics and gene editing are taking disease resistance beyond general robustness towards targeted protection. Dr Craig Lewis and Dr Andrey Pavlov explore research into PRRS resistance and the potential implications for African swine fever and foot-and-mouth disease.
Genetics complements—not replaces—biosecurity, vaccination and strong farm management.
Read more in the full article: 
Contact:
Contact us using the following form.